HEADER TRANSFERASE/INHIBITOR 17-MAY-23 8JF3 TITLE C-SRC IN COMPLEX WITH COMPOUND 9 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PROTO-ONCOGENE C-SRC,PP60C-SRC,P60-SRC; COMPND 5 EC: 2.7.10.2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SRC, SRC1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Z.M.ZHANG,H.S.HUANG REVDAT 2 27-MAR-24 8JF3 1 JRNL REVDAT 1 14-FEB-24 8JF3 0 JRNL AUTH G.TANG,W.WANG,C.ZHU,H.HUANG,P.CHEN,X.WANG,M.XU,J.SUN, JRNL AUTH 2 C.J.ZHANG,Q.XIAO,L.GAO,Z.M.ZHANG,S.Q.YAO JRNL TITL GLOBAL REACTIVITY PROFILING OF THE CATALYTIC LYSINE IN HUMAN JRNL TITL 2 KINOME FOR COVALENT INHIBITOR DEVELOPMENT. JRNL REF ANGEW.CHEM.INT.ED.ENGL. V. 63 16394 2024 JRNL REFN ESSN 1521-3773 JRNL PMID 38248139 JRNL DOI 10.1002/ANIE.202316394 REMARK 2 REMARK 2 RESOLUTION. 2.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692+SVN REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 62.21 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.973 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 3 NUMBER OF REFLECTIONS : 16770 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.278 REMARK 3 R VALUE (WORKING SET) : 0.274 REMARK 3 FREE R VALUE : 0.317 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.048 REMARK 3 FREE R VALUE TEST SET COUNT : 1685 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 10.0000 - 6.5145 0.94 1231 138 0.2495 0.2580 REMARK 3 2 6.5145 - 5.1716 0.97 1253 142 0.2807 0.3069 REMARK 3 3 5.1716 - 4.5181 0.96 1242 138 0.2467 0.2895 REMARK 3 4 4.5181 - 4.1051 0.96 1267 139 0.2456 0.3000 REMARK 3 5 4.1051 - 3.8109 0.96 1228 141 0.2652 0.3020 REMARK 3 6 3.8109 - 3.5862 0.96 1278 148 0.2762 0.3387 REMARK 3 7 3.5862 - 3.4066 0.97 1257 141 0.2852 0.3370 REMARK 3 8 3.4066 - 3.2583 0.97 1257 137 0.2729 0.3169 REMARK 3 9 3.2583 - 3.1329 0.97 1264 142 0.3027 0.3507 REMARK 3 10 3.1329 - 3.0248 0.97 1263 140 0.3146 0.3870 REMARK 3 11 3.0248 - 2.9302 0.98 1267 129 0.3159 0.3813 REMARK 3 12 2.9302 - 2.8465 0.97 1278 150 0.3236 0.3685 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.507 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 35.325 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 34.37 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.21 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 3949 REMARK 3 ANGLE : 0.665 5365 REMARK 3 CHIRALITY : 0.023 585 REMARK 3 PLANARITY : 0.003 674 REMARK 3 DIHEDRAL : 14.997 1441 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8JF3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 25-MAY-23. REMARK 100 THE DEPOSITION ID IS D_1300037735. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-SEP-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CAMD REMARK 200 BEAMLINE : GCPCC REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.987 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 300K REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16792 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.840 REMARK 200 RESOLUTION RANGE LOW (A) : 72.230 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.84 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.94 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.84 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 300 MM SODIUM ACETATE, 0.1 M MES PH REMARK 280 7.5, 4% PEG3350, PH 6.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 254 REMARK 465 THR A 255 REMARK 465 GLN A 256 REMARK 465 GLY A 257 REMARK 465 LEU A 258 REMARK 465 ALA A 259 REMARK 465 LEU A 272 REMARK 465 GLU A 273 REMARK 465 GLN A 278 REMARK 465 GLY A 279 REMARK 465 CYS A 280 REMARK 465 PHE A 281 REMARK 465 GLY A 282 REMARK 465 LEU A 300 REMARK 465 LYS A 301 REMARK 465 PRO A 302 REMARK 465 GLY A 303 REMARK 465 THR A 304 REMARK 465 MET A 305 REMARK 465 SER A 306 REMARK 465 PRO A 307 REMARK 465 GLU A 308 REMARK 465 ALA A 309 REMARK 465 PHE A 310 REMARK 465 LEU A 311 REMARK 465 GLN A 312 REMARK 465 GLU A 313 REMARK 465 ILE A 414 REMARK 465 GLU A 415 REMARK 465 ASP A 416 REMARK 465 ASN A 417 REMARK 465 GLU A 418 REMARK 465 TYR A 419 REMARK 465 THR A 420 REMARK 465 ALA A 421 REMARK 465 ARG A 422 REMARK 465 GLN A 423 REMARK 465 GLY A 424 REMARK 465 ALA A 425 REMARK 465 LYS A 426 REMARK 465 PHE A 427 REMARK 465 GLN B 254 REMARK 465 THR B 255 REMARK 465 GLN B 256 REMARK 465 GLY B 257 REMARK 465 LEU B 258 REMARK 465 ALA B 259 REMARK 465 LYS B 260 REMARK 465 LEU B 270 REMARK 465 ARG B 271 REMARK 465 GLN B 278 REMARK 465 GLY B 279 REMARK 465 CYS B 280 REMARK 465 PHE B 281 REMARK 465 LYS B 301 REMARK 465 PRO B 302 REMARK 465 GLY B 303 REMARK 465 THR B 304 REMARK 465 MET B 305 REMARK 465 SER B 306 REMARK 465 PRO B 307 REMARK 465 GLU B 308 REMARK 465 ALA B 309 REMARK 465 PHE B 310 REMARK 465 LEU B 311 REMARK 465 GLN B 312 REMARK 465 GLU B 313 REMARK 465 GLY B 409 REMARK 465 LEU B 410 REMARK 465 ALA B 411 REMARK 465 ARG B 412 REMARK 465 LEU B 413 REMARK 465 ILE B 414 REMARK 465 GLU B 415 REMARK 465 ASP B 416 REMARK 465 ASN B 417 REMARK 465 GLU B 418 REMARK 465 TYR B 419 REMARK 465 THR B 420 REMARK 465 ALA B 421 REMARK 465 ARG B 422 REMARK 465 GLN B 423 REMARK 465 GLY B 424 REMARK 465 ALA B 425 REMARK 465 LYS B 426 REMARK 465 PHE B 427 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 267 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 268 CG CD OE1 OE2 REMARK 470 LYS A 275 CG CD CE NZ REMARK 470 THR A 292 OG1 CG2 REMARK 470 GLN A 315 CG CD OE1 NE2 REMARK 470 LYS A 319 CG CD CE NZ REMARK 470 GLU A 334 CG CD OE1 OE2 REMARK 470 GLU A 335 CG CD OE1 OE2 REMARK 470 LYS A 346 CG CD CE NZ REMARK 470 HIS A 387 CG ND1 CD2 CE1 NE2 REMARK 470 SER A 493 OG REMARK 470 GLU A 534 CG CD OE1 OE2 REMARK 470 GLU B 268 CG CD OE1 OE2 REMARK 470 LYS B 275 CG CD CE NZ REMARK 470 GLU B 283 CG CD OE1 OE2 REMARK 470 LEU B 300 CG CD1 CD2 REMARK 470 GLN B 315 CG CD OE1 NE2 REMARK 470 LYS B 319 CG CD CE NZ REMARK 470 GLU B 334 CG CD OE1 OE2 REMARK 470 TYR B 338 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS B 461 CG CD CE NZ REMARK 470 ARG B 472 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 476 CG OD1 OD2 REMARK 470 SER B 493 OG REMARK 470 GLU B 505 CG CD OE1 OE2 REMARK 470 GLN B 529 CG CD OE1 NE2 REMARK 470 GLN B 531 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS A 298 S1 C0N A 601 1.46 REMARK 500 NZ LYS B 298 S1 C0N B 601 1.52 REMARK 500 OH TYR A 530 OXT LEU A 536 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 276 -58.20 -127.19 REMARK 500 TRP A 289 -89.63 -75.09 REMARK 500 ASN A 290 40.04 -103.33 REMARK 500 THR A 292 -1.90 -143.75 REMARK 500 ASP A 389 57.82 -157.53 REMARK 500 ASP A 407 87.21 55.73 REMARK 500 TRP A 502 59.34 -106.71 REMARK 500 ARG B 267 59.65 -67.12 REMARK 500 GLU B 268 132.89 -170.60 REMARK 500 GLU B 273 -56.33 -135.32 REMARK 500 ASP B 389 53.22 -162.73 REMARK 500 ASP B 407 -93.47 67.82 REMARK 500 GLU B 489 19.66 59.90 REMARK 500 GLN B 529 34.78 -97.13 REMARK 500 REMARK 500 REMARK: NULL DBREF 8JF3 A 254 536 UNP P12931 SRC_HUMAN 254 536 DBREF 8JF3 B 254 536 UNP P12931 SRC_HUMAN 254 536 SEQRES 1 A 283 GLN THR GLN GLY LEU ALA LYS ASP ALA TRP GLU ILE PRO SEQRES 2 A 283 ARG GLU SER LEU ARG LEU GLU VAL LYS LEU GLY GLN GLY SEQRES 3 A 283 CYS PHE GLY GLU VAL TRP MET GLY THR TRP ASN GLY THR SEQRES 4 A 283 THR ARG VAL ALA ILE LYS THR LEU LYS PRO GLY THR MET SEQRES 5 A 283 SER PRO GLU ALA PHE LEU GLN GLU ALA GLN VAL MET LYS SEQRES 6 A 283 LYS LEU ARG HIS GLU LYS LEU VAL GLN LEU TYR ALA VAL SEQRES 7 A 283 VAL SER GLU GLU PRO ILE TYR ILE VAL THR GLU TYR MET SEQRES 8 A 283 SER LYS GLY SER LEU LEU ASP PHE LEU LYS GLY GLU THR SEQRES 9 A 283 GLY LYS TYR LEU ARG LEU PRO GLN LEU VAL ASP MET ALA SEQRES 10 A 283 ALA GLN ILE ALA SER GLY MET ALA TYR VAL GLU ARG MET SEQRES 11 A 283 ASN TYR VAL HIS ARG ASP LEU ARG ALA ALA ASN ILE LEU SEQRES 12 A 283 VAL GLY GLU ASN LEU VAL CYS LYS VAL ALA ASP PHE GLY SEQRES 13 A 283 LEU ALA ARG LEU ILE GLU ASP ASN GLU TYR THR ALA ARG SEQRES 14 A 283 GLN GLY ALA LYS PHE PRO ILE LYS TRP THR ALA PRO GLU SEQRES 15 A 283 ALA ALA LEU TYR GLY ARG PHE THR ILE LYS SER ASP VAL SEQRES 16 A 283 TRP SER PHE GLY ILE LEU LEU THR GLU LEU THR THR LYS SEQRES 17 A 283 GLY ARG VAL PRO TYR PRO GLY MET VAL ASN ARG GLU VAL SEQRES 18 A 283 LEU ASP GLN VAL GLU ARG GLY TYR ARG MET PRO CYS PRO SEQRES 19 A 283 PRO GLU CYS PRO GLU SER LEU HIS ASP LEU MET CYS GLN SEQRES 20 A 283 CYS TRP ARG LYS GLU PRO GLU GLU ARG PRO THR PHE GLU SEQRES 21 A 283 TYR LEU GLN ALA PHE LEU GLU ASP TYR PHE THR SER THR SEQRES 22 A 283 GLU PRO GLN TYR GLN PRO GLY GLU ASN LEU SEQRES 1 B 283 GLN THR GLN GLY LEU ALA LYS ASP ALA TRP GLU ILE PRO SEQRES 2 B 283 ARG GLU SER LEU ARG LEU GLU VAL LYS LEU GLY GLN GLY SEQRES 3 B 283 CYS PHE GLY GLU VAL TRP MET GLY THR TRP ASN GLY THR SEQRES 4 B 283 THR ARG VAL ALA ILE LYS THR LEU LYS PRO GLY THR MET SEQRES 5 B 283 SER PRO GLU ALA PHE LEU GLN GLU ALA GLN VAL MET LYS SEQRES 6 B 283 LYS LEU ARG HIS GLU LYS LEU VAL GLN LEU TYR ALA VAL SEQRES 7 B 283 VAL SER GLU GLU PRO ILE TYR ILE VAL THR GLU TYR MET SEQRES 8 B 283 SER LYS GLY SER LEU LEU ASP PHE LEU LYS GLY GLU THR SEQRES 9 B 283 GLY LYS TYR LEU ARG LEU PRO GLN LEU VAL ASP MET ALA SEQRES 10 B 283 ALA GLN ILE ALA SER GLY MET ALA TYR VAL GLU ARG MET SEQRES 11 B 283 ASN TYR VAL HIS ARG ASP LEU ARG ALA ALA ASN ILE LEU SEQRES 12 B 283 VAL GLY GLU ASN LEU VAL CYS LYS VAL ALA ASP PHE GLY SEQRES 13 B 283 LEU ALA ARG LEU ILE GLU ASP ASN GLU TYR THR ALA ARG SEQRES 14 B 283 GLN GLY ALA LYS PHE PRO ILE LYS TRP THR ALA PRO GLU SEQRES 15 B 283 ALA ALA LEU TYR GLY ARG PHE THR ILE LYS SER ASP VAL SEQRES 16 B 283 TRP SER PHE GLY ILE LEU LEU THR GLU LEU THR THR LYS SEQRES 17 B 283 GLY ARG VAL PRO TYR PRO GLY MET VAL ASN ARG GLU VAL SEQRES 18 B 283 LEU ASP GLN VAL GLU ARG GLY TYR ARG MET PRO CYS PRO SEQRES 19 B 283 PRO GLU CYS PRO GLU SER LEU HIS ASP LEU MET CYS GLN SEQRES 20 B 283 CYS TRP ARG LYS GLU PRO GLU GLU ARG PRO THR PHE GLU SEQRES 21 B 283 TYR LEU GLN ALA PHE LEU GLU ASP TYR PHE THR SER THR SEQRES 22 B 283 GLU PRO GLN TYR GLN PRO GLY GLU ASN LEU HET C0N A 601 39 HET C0N B 601 39 HETNAM C0N 2-[4-[4-[BIS(OXIDANYLIDENE)-$L^5- HETNAM 2 C0N SULFANYL]OXYPHENYL]CARBONYLPIPERAZIN-1-YL]-6-[(5- HETNAM 3 C0N CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]-N-PROP-2-YNYL- HETNAM 4 C0N PYRIMIDINE-4-CARBOXAMIDE FORMUL 3 C0N 2(C25 H25 N8 O5 S 1+) HELIX 1 AA1 LEU A 349 GLY A 355 1 7 HELIX 2 AA2 GLU A 356 TYR A 360 5 5 HELIX 3 AA3 ARG A 362 MET A 383 1 22 HELIX 4 AA4 ARG A 391 ALA A 393 5 3 HELIX 5 AA5 GLU A 399 LEU A 401 5 3 HELIX 6 AA6 ALA A 433 TYR A 439 1 7 HELIX 7 AA7 THR A 443 THR A 459 1 17 HELIX 8 AA8 VAL A 470 ARG A 480 1 11 HELIX 9 AA9 PRO A 491 TRP A 502 1 12 HELIX 10 AB1 GLU A 505 ARG A 509 5 5 HELIX 11 AB2 THR A 511 ASP A 521 1 11 HELIX 12 AB3 ASP A 521 THR A 526 1 6 HELIX 13 AB4 SER B 348 GLY B 355 1 8 HELIX 14 AB5 THR B 357 LEU B 361 5 5 HELIX 15 AB6 ARG B 362 MET B 383 1 22 HELIX 16 AB7 ARG B 391 ALA B 393 5 3 HELIX 17 AB8 GLU B 399 LEU B 401 5 3 HELIX 18 AB9 ALA B 433 LEU B 438 1 6 HELIX 19 AC1 THR B 443 THR B 460 1 18 HELIX 20 AC2 VAL B 470 ARG B 480 1 11 HELIX 21 AC3 PRO B 491 TRP B 502 1 12 HELIX 22 AC4 THR B 511 ASP B 521 1 11 HELIX 23 AC5 ASP B 521 THR B 526 1 6 SHEET 1 AA1 5 ARG A 271 ARG A 271 0 SHEET 2 AA1 5 VAL A 284 THR A 288 -1 O THR A 288 N ARG A 271 SHEET 3 AA1 5 ARG A 294 LYS A 298 -1 O ILE A 297 N TRP A 285 SHEET 4 AA1 5 ILE A 339 GLU A 342 -1 O THR A 341 N ALA A 296 SHEET 5 AA1 5 LEU A 328 VAL A 331 -1 N TYR A 329 O VAL A 340 SHEET 1 AA2 3 GLY A 347 SER A 348 0 SHEET 2 AA2 3 ILE A 395 VAL A 397 -1 O VAL A 397 N GLY A 347 SHEET 3 AA2 3 CYS A 403 VAL A 405 -1 O LYS A 404 N LEU A 396 SHEET 1 AA3 5 VAL B 274 GLY B 277 0 SHEET 2 AA3 5 VAL B 284 TRP B 289 -1 O MET B 286 N VAL B 274 SHEET 3 AA3 5 THR B 293 LYS B 298 -1 O THR B 293 N TRP B 289 SHEET 4 AA3 5 TYR B 338 GLU B 342 -1 O ILE B 339 N LYS B 298 SHEET 5 AA3 5 LEU B 328 VAL B 332 -1 N TYR B 329 O VAL B 340 SHEET 1 AA4 2 ILE B 395 VAL B 397 0 SHEET 2 AA4 2 CYS B 403 VAL B 405 -1 O LYS B 404 N LEU B 396 CISPEP 1 ALA A 314 GLN A 315 0 1.70 CISPEP 2 GLU A 335 PRO A 336 0 0.37 CISPEP 3 GLU B 268 SER B 269 0 1.97 CISPEP 4 THR B 299 LEU B 300 0 1.48 CISPEP 5 GLU B 335 PRO B 336 0 -0.54 CRYST1 41.716 63.427 73.649 101.21 91.05 90.16 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023972 0.000067 0.000460 0.00000 SCALE2 0.000000 0.015766 0.003127 0.00000 SCALE3 0.000000 0.000000 0.013845 0.00000